
Patients with lupus nephritis (LN) were found to have as much as twice the inpatient hospitalizations of patients with systemic lupus erythematosus without LN.
Jared is a freelance writer for The American Journal of Managed Care® (AJMC®), and previously worked as a senior editor for HCPLive® at MJH Life Sciences®.
He has an MA from University of Sioux Falls. You can connect with Jared on LinkedIn.
Patients with lupus nephritis (LN) were found to have as much as twice the inpatient hospitalizations of patients with systemic lupus erythematosus without LN.
A study suggests tumor in situ fluid is a better choice when trying to extract tumor DNA in patients with glioma who underwent surgery.
Cost increases were particularly pronounced among patients with severe systemic lupus erythematosus (SLE), the study found.
New data show the therapy led to minimal changes in renal function, even after more than 8 years.
Patients treated with immune checkpoint inhibitors had significantly different survival rates based on the test, regardless of PD ligand 1 classification.
The analysis found 20% of people with asthma, emphysema, or chronic bronchitis also have depression.
A new analysis suggests physicians should be on the lookout for cardiovascular disease and other types of cancer, in addition to acute myeloid lymphom, when caring for patients with certain myeloproliferative neoplasms (MPNs).
A new review article highlights some of the newest therapies available to treat graft-versus-host disease (GVHD), but the authors say there is insufficient data to draw broad conclusions.
In patients refractory to conventional therapy, the combination resulted in a 70% reduction in a key biomarker compared with placebo.
The report suggests factors besides molecular profiling can be helpful in patient stratification.
Twenty combinations of toxic pollutants were identified by a machine learning algorithm as being tied with asthma outcomes.
A new opinion piece makes the case that rheumatoid arthritis care can, and should, be better tailored to individual case characteristics.
The data suggest early factors in the home are the most important links to asthma risk in children.
An analysis of the latest research finds a robust approach to understanding particular prostate cancers remains necessary to finding optimal treatment.
Results of a pooled analysis showed patients with rheumatoid arthritis who take upadacitinib may be at increased risk of herpes zoster.
Patients with asthma have high rates of type 2 inflammatory disease, study finds.
New modeling could help explain why some patients develop resistance to tyrosine kinase inhibitors.
Three-quarters of patients said they were worried about the risks associated with SARS-CoV-2 infection.
A new review article highlights the importance of developing asthma action plans and clear lines of communication.
Duration of rheumatoid arthritis and use of corticosteroids were associated with higher risk of adverse outcomes following coronary artery bypass graft (CABG).
The case suggests lung transplantation can be a feasible option for patients with lung involvement.
Patients with rheumatoid arthritis (RA) who suffer from malnutrition were more likely to be frail and face mental health challenges.
Acid sphingomyelinase deficiency (ASMD) is a rare lysosomal storage disorder; a new report said that plasma lyso-sphingomyelin levels can be used to not only diagnose the rare disease but also predict severity and type.
A new study suggests the lower-cost, more patient-friendly assessment method may be a useful tool for clinicians.
This new study adds to the literature by giving the first long-term data in these populations.
When patients are quickly readmitted, they have higher health care costs, a new study has found.
A look at the existing literature suggests more questions than answers remain when it comes to the potential use of the cholinergic anti-inflammatory pathway in connective tissue diseases (CTDs).
A minority of patients will experience flares, but in most cases reintroduction of therapy will result in remission.
The reports suggest patients with rheumatoid arthritis (RA) could experience secondary neurological adverse events, though the side effect appears to be rare.
Intravenous belimumab had benefits, but also resulted in more health care utilization due to the nature of its administration.
259 Prospect Plains Rd, Bldg H
Cranbury, NJ 08512
© 2025 MJH Life Sciences®
All rights reserved.